Pharmalucence Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?
PHARMALUCENCE has six approved drugs.
Drugs and US Patents for Pharmalucence
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmalucence | IODOHIPPURATE SODIUM I 131 | iodohippurate sodium i-131 | INJECTABLE;INJECTION | 017313-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pharmalucence | SODIUM PERTECHNETATE TC 99M | technetium tc-99m sodium pertechnetate | SOLUTION;INJECTION, ORAL | 017321-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pharmalucence | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pharmalucence
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | 4,584,187 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.